BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9546064)

  • 21. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.
    Olumi AF; Tsai YC; Nichols PW; Skinner DG; Cain DR; Bender LI; Jones PA
    Cancer Res; 1990 Nov; 50(21):7081-3. PubMed ID: 2208176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chromosomal analysis of primary superficial tumors of the bladder].
    Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
    J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Karyotypic characterization of urinary bladder transitional cell carcinomas.
    Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
    Genes Chromosomes Cancer; 2000 Nov; 29(3):256-65. PubMed ID: 10992300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A possible specific chromosome change in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Pontes JE; Connolly JG; Sandberg AA
    Cancer Genet Cytogenet; 1986 Jan; 19(3-4):229-38. PubMed ID: 3943046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
    Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomes in kidney, ureter, and bladder cancer.
    Berger CS; Sandberg AA; Todd IA; Pennington RD; Haddad FS; Hecht BK; Hecht F
    Cancer Genet Cytogenet; 1986 Sep; 23(1):1-24. PubMed ID: 3742484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent chromosome alterations in transitional cell bladder carcinomas.
    Matturri L; Lavezzi AM
    Eur J Histochem; 1992; 36(2):177-86. PubMed ID: 1380851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic heterogeneity in a second primary radiation-induced bladder carcinoma: ten karyotypically unrelated clones.
    Fadl-Elmula I; Bonaldi L; Gorunova L; Mandahl N; Elfving P; Heim S
    Cancer Genet Cytogenet; 1998 Sep; 105(2):134-7. PubMed ID: 9723030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marker chromosome stability associated with neoplastic transformation of human uroepithelial cells.
    Wu SQ; Christian BJ; Reznikoff CA; Meisner LF
    Cancer Genet Cytogenet; 1988 Nov; 36(1):77-87. PubMed ID: 2849503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
    Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
    Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder.
    Kunze E
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):341-55. PubMed ID: 9784006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome changes in bladder cancer: clinical and other correlations.
    Sandberg AA
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):163-75. PubMed ID: 3455662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of chromosomal imbalances in muscle invasive bladder cancer.
    Simon R; Burger H; Semjonow A; Hertle L; Terpe HJ; Bocker W
    Int J Oncol; 2000 Nov; 17(5):1025-9. PubMed ID: 11029508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
    Southgate J; Proffitt J; Roberts P; Smith B; Selby P
    Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
    Makboul R; Refaiy AE; Badary FA; Abdelkawi IF; Merseburger AS; Mohammed RA
    Korean J Urol; 2015 Jan; 56(1):31-40. PubMed ID: 25598934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent and noncontiguous squamous and transitional cell carcinomas of a bladder.
    Tabibzadeh SS; Rybak BJ; Falcone R
    Mt Sinai J Med; 1986 Feb; 53(2):129-33. PubMed ID: 3486350
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
    Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
    Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular alterations of E-cadherin gene: possible role in human bladder carcinogenesis.
    Taddei I; Piazzini M; Bartoletti R; Dal Canto M; Sardi I
    Int J Mol Med; 2000 Aug; 6(2):201-8. PubMed ID: 10891567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.